Kestra Advisory Services’s Transmedics TMDX Stock Holding History

Kestra Advisory Services’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$524K	Sell	5,272 -397	-7%	-$51.8K	﹤0.01%	2182
2025 Q4	$690K	Sell	5,669 -936	-14%	-$117K	﹤0.01%	1923
2025 Q3	$741K	Buy	6,605 +624	+10%	+$73K	﹤0.01%	1798
2025 Q2	$802K	Buy	5,981 +1,430	+31%	+$157K	﹤0.01%	1637
2025 Q1	$306K	Sell	4,551 -548	-11%	-$37.7K	﹤0.01%	2158
2024 Q4	$318K	Buy	5,099 +2,479	+95%	+$231K	﹤0.01%	2179
2024 Q3	$411K	Sell	2,620 -1,294	-33%	-$199K	﹤0.01%	1889
2024 Q2	$590K	Buy	+3,914	New	+$469K	﹤0.01%	1669

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kestra Advisory Services's TMDX Position: Q1 2026 in Review

Kestra Advisory Services reduced its Transmedics (TMDX) stake by 7% in Q1 2026, selling an estimated $51.8K and leaving 5,272 shares worth $524K. The position accounts for ﹤0.01% of the portfolio, ranked #2182.

Kestra Advisory Services first reported a position in TMDX in Q2 2024 and has held it in 8 quarters since. The position peaked at $802K in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Kestra Advisory Services held 5,272 shares of Transmedics worth $524K as of Q1 2026.
Kestra Advisory Services sold 397 Transmedics shares in Q1 2026, an estimated $51.8K.
Transmedics made up ﹤0.01% of Kestra Advisory Services's portfolio in Q1 2026, its #2182 holding.
Kestra Advisory Services first reported a position in Transmedics in Q2 2024 and has held it in 8 quarters since.
Kestra Advisory Services's Transmedics position peaked at $802K in Q2 2025.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.